# Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease

> **NCT01393665** · PHASE2 · COMPLETED · sponsor: **PharmaKing** · enrollment: 88 (actual)

## Conditions studied

- Chronic Liver Disease

## Interventions

- **DRUG:** PENNEL capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01393665
- **Lead sponsor:** PharmaKing
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-12
- **Primary completion:** 1997-05
- **Final completion:** 1997-10
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2011-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01393665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01393665, "Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01393665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*